Get the app
public
ios_share
OncoPharm
chevron_right
Lenvatinib vs. Sorafenib (HCC)
Apr 24, 2019
11:52
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Reviewing the REFLECT (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30207-1/fulltext) study and its take-home points on selecting an agent for advanced HCC.
